Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Hematol ; 90(5): 571-575, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19866337

RESUMEN

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by a defect of phagocyte NADPH-oxidase and characterized by severe, recurrent bacterial and fungal infections. Invasive aspergillosis (IA) is the leading cause of mortality in patients with CGD. We report the case of a 3-year-old boy with CGD, who developed IA despite antifungal prophylaxis. His treatment consisted of a 10-month-long multi-drug antifungal therapy, together with surgery, but these did not cause any substantial clinical improvement. BMT in high-risk patients with CGD remains a challenge due to both, higher risk of graft rejection and inflammatory flare in the course of immune recovery. Our patient rejected the first matched unrelated donor (MUD) allograft after RIC regimen recommended by the EBMT Inborn Errors Working Party for high-risk patients. After treosulfan-based conditioning and second MUD peripheral blood stem cell transplantation both, full reconstitution of the granulocytic series and complete recovery from IA, were achieved.


Asunto(s)
Aspergilosis/terapia , Busulfano/análogos & derivados , Enfermedad Granulomatosa Crónica/terapia , Trasplante de Células Madre de Sangre Periférica/métodos , Reoperación/métodos , Acondicionamiento Pretrasplante/métodos , Antineoplásicos Alquilantes/uso terapéutico , Busulfano/uso terapéutico , Preescolar , Supervivencia de Injerto , Enfermedad Granulomatosa Crónica/complicaciones , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA